- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01903395
Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer (FAMKOL)
Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy
BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk for colorectal cancer as well. Nevertheless, participation in the German national screening program stagnates at 2-3 percent per year even in this high-risk population.
AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which take up a preventive colonoscopy.
METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly certified cancer centers and office-based gastroenterologists from all over Germany. Index-patients with colorectal cancer of different stages are asked to hand over the study material to their relatives, consisting of an invitation to a nurse-led counseling on preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the study sites next.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Baden-Würtemberg
-
Ludwigsburg, Baden-Würtemberg, Germany, 71640
- Klinikum Ludwigsburg
-
Mannheim, Baden-Würtemberg, Germany, 68163
- Diakoniekrankenhaus Mannheim
-
Stuttgart, Baden-Würtemberg, Germany, 70374
- Klinikum Stuttgart Krankenhaus Bad Cannstatt
-
Ulm, Baden-Würtemberg, Germany, 89081
- Universitatsklinikum Ulm
-
-
Baden-Württemberg
-
Sigmaringen, Baden-Württemberg, Germany, 72488
- Kliniken Landkreis Sigmaringen GmbH
-
-
Bayern
-
Aschaffenburg, Bayern, Germany, 63739
- Klinikum Aschaffenburg
-
Erlangen, Bayern, Germany, 91054
- Universitatsklinikum Erlangen
-
Würzburg, Bayern, Germany, 97070
- Stiftung Juliusspital Würzburg
-
-
Brandenburg
-
Eberswalde, Brandenburg, Germany, 16225
- Klinikum Barnim
-
-
Hessen
-
Hanau, Hessen, Germany, 63450
- Klinikum Hanau
-
Marburg, Hessen, Germany, 35043
- Universitätsklinikum Giessen und Marburg
-
-
Mecklenburg-Vorpommern
-
Schwerin, Mecklenburg-Vorpommern, Germany, 19049
- HELIOS Kliniken Schwerin
-
-
Niedersachsen
-
Braunschweig, Niedersachsen, Germany, 38126
- Städtisches Klinikum Braunschweig
-
Celle, Niedersachsen, Germany, 29223
- Allgemeines Krankenhaus Celle
-
Lüneburg, Niedersachsen, Germany, 21339
- Stadtisches Klinikum Luneburg
-
Osnabrück, Niedersachsen, Germany, 49076
- Klinikum Osnabrück GmbH
-
-
Nordrhein-Westfalen
-
Duisburg, Nordrhein-Westfalen, Germany, 47228
- Johanniter-Krankenhaus Rheinhausen
-
Gütersloh, Nordrhein-Westfalen, Germany, 33332
- Sankt Elisabeth Hospital Gütersloh
-
Köln, Nordrhein-Westfalen, Germany, 51067
- Krankenhaus Köln-Holweide
-
Köln, Nordrhein-Westfalen, Germany, 51103
- Klinik Evang. Krankenhaus Kalk
-
Lüdenscheid, Nordrhein-Westfalen, Germany, 58515
- Klinikum Lüdenscheid
-
-
Nordrhein-Wetsfalen
-
Bochum, Nordrhein-Wetsfalen, Germany, 44892
- Universitätsklinikum Knappschaftskrankenhaus Ruhr Universität Bochum
-
-
Rheinland-Pfalz
-
Bad Kreuznach, Rheinland-Pfalz, Germany, 55543
- Krankenhaus St. Marienwörth
-
Speyer, Rheinland-Pfalz, Germany, 67346
- Diakonissen-Stiftungs-Krankenhaus Speyer
-
-
Saarland
-
Völklingen, Saarland, Germany, 66333
- Gastroenterologische Schwerpunktpraxis Völklingen
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04177
- Evangelisches Diakonissenkrankenhaus Leipzig gGmbH
-
-
Sachsen-Anhalt
-
Dessau-Roßlau, Sachsen-Anhalt, Germany, 06846
- Diakonissenkrankenhaus Dessau gemeinnützige GmbH
-
Lutherstadt Wittenberg, Sachsen-Anhalt, Germany, 06886
- Evangelisches Krankenhaus Paul Gerhardt Stift
-
Lutherstadt Wittenberg, Sachsen-Anhalt, Germany, 06886
- Praxis für Innere Medizin Dr. med. Regine Lange
-
Magdeburg, Sachsen-Anhalt, Germany, 39130
- Klinikum Magdeburg gemeinnützige GmbH
-
Sangerhausen, Sachsen-Anhalt, Germany, 06526
- HELIOS Klinik Sangerhausen
-
-
Schleswig-Holstein
-
Heide, Schleswig-Holstein, Germany, 25746
- Westküstenklinikum Heide
-
-
Thüringen
-
Jena, Thüringen, Germany, 07747
- Universitätsklinikum Jena
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 18 and over
- being first-degree relatives of patients with diagnosed colorectal cancer
- able to understand German
Exclusion Criteria:
- Familial Adenomatous Polyposis
- utilization of diagnostic colonoscopy within the past 5 years
- being ever treated for colorectal cancer
- actual inflammatory bowl disease
- comorbidities associated with reduced further life expectancy (ECOG performance status >3
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nurse-led counselling
First-degree relatives of patients undergoing active treatment for colorectal cancer are offered a nurse-led counselling by telephone regarding emotional and cognitive barriers to screening utilization.
|
Nurse-led telephone counselling to double the utilization of preventive colonoscopy
|
No Intervention: Usual Care
Usual print media, offered standardly by the recruiting centres.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
utilization of preventive colonoscopy
Time Frame: utilization within 30 days after enrolement
|
utilization within 30 days after enrolement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of advanced adenomas or carcinomas in situ
Time Frame: Rate within 6 month after enrolement
|
Rate within 6 month after enrolement
|
|
post-operative complications associated with the colonoscopy
Time Frame: within 30 days after enrolement
|
within 30 days after enrolement
|
|
barriers to the use of preventive colonoscopy
Time Frame: within 30 day after enrolement, additional at 6 months after enrolement
|
Barriers against preventive colonoscopy are very common among the healthy population. Such barriers can bei either of cognitive (e.g. being afraid of the potential diagnosis) or emotional nature (e.g. shame to be exposed naked to the examiners). Barriers are assessed by Barriers Questionnaire-II (BQ-II) during telephone counselling. |
within 30 day after enrolement, additional at 6 months after enrolement
|
effectiveness and cost-effectiveness of nurse-led counselling
Time Frame: within 30 days after enrolement
|
within 30 days after enrolement
|
|
time delay between signed informed consent and utilization of colonoscopy
Time Frame: at utilization of the colonoscopy
|
at utilization of the colonoscopy
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexander Bauer, PhD, Martin-Luther-University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NKP332-032
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasms
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...Active, not recruitingColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
Pawel KalinskiNational Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
Jeremy MeyerUniversity Hospital, Geneva; Hôpital Fribourgeois; Spital Biel, SwitzerlandNot yet recruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Neoplasms, Benign
-
ProgenaBiomeRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal SarcomaUnited States
-
Bristol-Myers SquibbNovartisActive, not recruitingColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaItaly, United States, Canada, Spain, Argentina, Australia, Belgium, Chile, Czechia, Germany
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Disorders | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Adenomatous Polyp | Colorectal Cancer Stage I | Colorectal Adenoma... and other conditionsUnited States, Italy, China, Spain, Japan
Clinical Trials on Nurse-led counselling
-
Helse Nord-Trøndelag HFCompletedMyocardial Infarction | Cardiovascular Diseases | Coronary DiseaseNorway
-
Spenshult HospitalThe Swedish Rheumatism Ass; County Council of Halland, SwedenUnknownRheumatic DiseasesSweden
-
Radboud University Medical CenterCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedRheumatoid Arthritis (RA) | Spondyloarthritis (SpA)France
-
Hospices Civils de LyonCompletedType 1 DiabetesFrance
-
Gia Dinh People HospitalNot yet recruitingAnticoagulants; Circulating, Hemorrhagic Disorder
-
University of DundeeCompleted
-
University of Texas Southwestern Medical CenterCompletedMultidisciplinary CommunicationUnited States
-
The University of Hong KongRecruiting
-
Cancer Care OntarioCanadian Institutes of Health Research (CIHR)Completed